| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.338 | 0.056 | 0.638 | Spasmolytic | 0.221 0.105 DBMET03746 0.491 0.024 DBMET03748 0.317 0.064 DBMET03749 0.638 0.01 DBMET03750 0.179 0.138 DBMET03747 | DBMET03750 | |
| 0.314 | 0.09 | 0.411 | Vasodilator, peripheral | 0.334 0.081 DBMET03746 0.411 0.052 DBMET03748 0.335 0.08 DBMET03749 0.289 0.102 DBMET03750 0.375 0.064 DBMET03747 | DBMET03748 | |
| 0.299 | 0.08 | 0.349 | Sodium/bile acid cotransporter inhibitor | 0.317 0.064 DBMET03746 0.206 0.18 DBMET03748 0.275 0.103 DBMET03749 0.349 0.04 DBMET03750 | DBMET03750 | |
| 0.326 | 0.123 | 0.43 | Analgesic | 0.317 0.129 DBMET03746 0.23 0.203 DBMET03748 0.31 0.134 DBMET03749 0.43 0.072 DBMET03750 | DBMET03750 | |
| 0.321 | 0.14 | 0.418 | Calcium channel L-type activator | 0.313 0.146 DBMET03746 0.361 0.109 DBMET03749 0.418 0.069 DBMET03750 | DBMET03750 | |
| 0.17 | 0.022 | 0.192 | Antineoplastic alkaloid | 0.192 0.016 DBMET03746 0.102 0.046 DBMET03748 0.175 0.021 DBMET03749 0.099 0.048 DBMET03750 0.104 0.045 DBMET03747 | DBMET03746 | |
| 0.23 | 0.082 | 0.371 | Vasodilator | 0.222 0.088 DBMET03746 0.371 0.028 DBMET03748 0.225 0.086 DBMET03749 0.237 0.077 DBMET03750 0.291 0.051 DBMET03747 | DBMET03748 | |
| 0.306 | 0.168 | 0.519 | Apoptosis agonist | 0.352 0.137 DBMET03746 0.519 0.069 DBMET03748 0.321 0.158 DBMET03749 0.477 0.081 DBMET03747 | DBMET03748 | |
| 0.264 | 0.145 | 0.43 | Histamine release inhibitor | 0.221 0.179 DBMET03746 0.275 0.138 DBMET03748 0.203 0.198 DBMET03749 0.43 0.06 DBMET03750 | DBMET03750 | |
| 0.181 | 0.07 | 0.24 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET03746 0.164 0.087 DBMET03749 0.24 0.037 DBMET03750 | DBMET03750 | |
| 0.133 | 0.028 | 0.186 | Acetylcholine M3 receptor agonist | 0.118 0.035 DBMET03749 0.186 0.006 DBMET03750 | DBMET03750 | |
| 0.245 | 0.152 | 0.321 | Toll-Like receptor 7 agonist | 0.209 0.19 DBMET03746 0.258 0.141 DBMET03749 0.321 0.098 DBMET03750 | DBMET03750 | |
| 0.127 | 0.037 | 0.167 | Toll-Like receptor 4 antagonist | 0.102 0.067 DBMET03746 0.167 0.013 DBMET03748 0.124 0.04 DBMET03749 0.123 0.04 DBMET03750 0.157 0.017 DBMET03747 | DBMET03748 | |
| 0.111 | 0.027 | 0.137 | Opioid kappa receptor antagonist | 0.137 0.019 DBMET03746 0.078 0.061 DBMET03748 0.099 0.035 DBMET03749 0.073 0.069 DBMET03747 | DBMET03746 | |
| 0.239 | 0.158 | 0.315 | Toll-Like receptor agonist | 0.202 0.199 DBMET03746 0.256 0.143 DBMET03749 0.315 0.101 DBMET03750 | DBMET03750 | |
| 0.237 | 0.159 | 0.395 | Immunosuppressant | 0.242 0.155 DBMET03746 0.395 0.065 DBMET03748 0.219 0.178 DBMET03749 0.386 0.069 DBMET03750 0.319 0.103 DBMET03747 | DBMET03748 | |
| 0.11 | 0.042 | 0.11 | mTOR complex 1 inhibitor | 0.106 0.05 DBMET03746 0.107 0.048 DBMET03749 | ||
| 0.219 | 0.155 | 0.577 | Antithrombotic | 0.577 0.019 DBMET03748 0.254 0.123 DBMET03749 0.449 0.038 DBMET03750 0.28 0.103 DBMET03747 | DBMET03748 | |
| 0.126 | 0.062 | 0.245 | Anesthetic local | 0.094 0.089 DBMET03749 0.245 0.021 DBMET03750 | DBMET03750 | |
| 0.205 | 0.151 | 0.298 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.298 0.066 DBMET03746 0.197 0.16 DBMET03749 | DBMET03746 | |
| 0.065 | 0.016 | 0.065 | Alpha 1L adrenoreceptor antagonist | 0.054 0.032 DBMET03746 0.06 0.022 DBMET03749 | ||
| 0.098 | 0.054 | 0.123 | Protein kinase C delta inhibitor | 0.123 0.035 DBMET03746 0.095 0.056 DBMET03748 0.093 0.059 DBMET03749 0.112 0.042 DBMET03747 | DBMET03746 | |
| 0.068 | 0.027 | 0.075 | Prolactin release inhibitor | 0.074 0.017 DBMET03746 0.075 0.015 DBMET03749 0.063 0.039 DBMET03750 0.059 0.058 DBMET03747 | DBMET03749 | |
| 0.131 | 0.093 | 0.189 | Diuretic | 0.189 0.049 DBMET03750 | DBMET03750 | |
| 0.124 | 0.088 | 0.14 | Neurotrophic factor | 0.14 0.069 DBMET03746 0.13 0.081 DBMET03749 0.125 0.087 DBMET03750 0.117 0.099 DBMET03747 | DBMET03746 | |
| 0.101 | 0.069 | 0.25 | AMP-activated protein kinase stimulant | 0.159 0.023 DBMET03746 0.25 0.007 DBMET03748 0.11 0.058 DBMET03749 0.162 0.021 DBMET03750 0.143 0.033 DBMET03747 | DBMET03748 | |
| 0.088 | 0.058 | 0.105 | Opioid antagonist | 0.105 0.044 DBMET03746 0.083 0.065 DBMET03749 | DBMET03746 | |
| 0.047 | 0.017 | 0.064 | Farnesoid X receptor agonist | 0.062 0.009 DBMET03746 0.034 0.032 DBMET03749 0.064 0.009 DBMET03750 | DBMET03750 | |
| 0.146 | 0.123 | 0.167 | P-glycoprotein inhibitor | 0.139 0.134 DBMET03746 0.167 0.093 DBMET03748 0.161 0.1 DBMET03747 | DBMET03748 | |
| 0.243 | 0.221 | 0.511 | Cyclophilin D inhibitor | 0.511 0.047 DBMET03748 0.3 0.163 DBMET03749 0.471 0.059 DBMET03750 0.378 0.103 DBMET03747 | DBMET03748 | |
| 0.037 | 0.019 | 0.037 | Somatostatin 5 antagonist | 0.028 0.024 DBMET03746 0.034 0.022 DBMET03749 0.028 0.025 DBMET03750 | ||
| 0.159 | 0.147 | 0.357 | Tumour necrosis factor alpha release inhibitor | 0.357 0.036 DBMET03748 0.174 0.131 DBMET03749 0.27 0.066 DBMET03747 | DBMET03748 | |
| 0.05 | 0.039 | 0.052 | 5 Hydroxytryptamine 4 antagonist | 0.052 0.035 DBMET03746 | DBMET03746 | |
| 0.101 | 0.095 | 0.316 | Cholinergic antagonist | 0.126 0.068 DBMET03749 0.316 0.013 DBMET03750 | DBMET03750 | |
| 0.028 | 0.023 | 0.028 | Complement C5a chemotactic receptor antagonist | |||
| 0.038 | 0.037 | 0.05 | Opioid kappa receptor agonist | 0.05 0.024 DBMET03746 | DBMET03746 | |
| 0.205 | 0.205 | 0.319 | Calcium channel activator | 0.214 0.193 DBMET03746 0.319 0.074 DBMET03750 | DBMET03750 | |
| 0.097 | 0.097 | 0.302 | Acetylcholine antagonist | 0.121 0.069 DBMET03749 0.302 0.014 DBMET03750 | DBMET03750 | |
| 0.047 | 0.049 | 0.101 | Protein kinase C eta inhibitor | 0.068 0.029 DBMET03746 0.087 0.021 DBMET03748 0.101 0.017 DBMET03747 | DBMET03747 | |
| 0.041 | 0.043 | 0.109 | Dopamine transporter inhibitor | 0.109 0.01 DBMET03750 | DBMET03750 | |
| 0.056 | 0.059 | 0.071 | Opioid mu receptor antagonist | 0.071 0.045 DBMET03746 | DBMET03746 | |
| 0.033 | 0.038 | 0.041 | Substance P antagonist | 0.036 0.032 DBMET03746 0.04 0.027 DBMET03749 0.041 0.026 DBMET03750 | DBMET03750 | |
| 0.03 | 0.036 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 DBMET03746 0.033 0.025 DBMET03748 0.033 0.023 DBMET03747 | DBMET03746 | |
| 0.159 | 0.165 | 0.197 | Cardiotonic | 0.197 0.122 DBMET03750 | DBMET03750 | |
| 0.063 | 0.073 | 0.068 | Analgesic, opioid | 0.068 0.064 DBMET03746 | DBMET03746 | |
| 0.033 | 0.044 | 0.037 | Acid-sensing ion channel blocker | 0.037 0.035 DBMET03746 | DBMET03746 | |
| 0.07 | 0.084 | 0.224 | Acetylcholine agonist | 0.224 0.011 DBMET03750 | DBMET03750 | |
| 0.023 | 0.037 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 DBMET03748 0.033 0.008 DBMET03750 | DBMET03750 | |
| 0.024 | 0.039 | 0.029 | Cholesterol ester transfer protein antagonist | 0.029 0.026 DBMET03750 | DBMET03750 | |
| 0.126 | 0.147 | 0.183 | Ca2+-transporting ATPase inhibitor | 0.183 0.006 DBMET03750 | DBMET03750 | |
| 0.04 | 0.061 | 0.072 | Acetylcholine M2 receptor agonist | 0.072 0.018 DBMET03750 | DBMET03750 | |
| 0.137 | 0.16 | 0.27 | Platelet antagonist | 0.227 0.084 DBMET03748 0.162 0.132 DBMET03749 0.27 0.064 DBMET03750 | DBMET03750 | |
| 0.061 | 0.084 | 0.165 | Acetylcholine nicotinic antagonist | 0.083 0.052 DBMET03749 0.165 0.017 DBMET03750 | DBMET03750 | |
| 0.042 | 0.064 | 0.056 | Opioid delta receptor antagonist | 0.056 0.049 DBMET03746 | DBMET03746 | |
| 0.082 | 0.106 | 0.264 | Beta glucuronidase inhibitor | 0.104 0.064 DBMET03746 0.264 0.008 DBMET03748 0.162 0.02 DBMET03747 | DBMET03748 | |
| 0.03 | 0.053 | 0.038 | Neurokinin 1 antagonist | 0.038 0.032 DBMET03750 | DBMET03750 | |
| 0.03 | 0.053 | 0.05 | Retinoic acid alpha receptor agonist | 0.05 0.014 DBMET03750 | DBMET03750 | |
| 0.042 | 0.07 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.051 DBMET03746 | DBMET03746 | |
| 0.04 | 0.068 | 0.062 | Glucose-6-phosphate translocase inhibitor | 0.062 0.022 DBMET03748 0.05 0.039 DBMET03747 | DBMET03748 | |
| 0.118 | 0.148 | 0.348 | Platelet adhesion inhibitor | 0.348 0.02 DBMET03748 0.182 0.081 DBMET03750 0.223 0.06 DBMET03747 | DBMET03748 | |
| 0.142 | 0.175 | 0.397 | Antioxidant | 0.172 0.14 DBMET03746 0.397 0.035 DBMET03748 0.361 0.044 DBMET03747 | DBMET03748 | |
| 0.251 | 0.285 | 0.3 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.3 0.213 DBMET03746 0.29 0.227 DBMET03750 | DBMET03746 | |
| 0.129 | 0.165 | 0.168 | Catenin beta inhibitor | 0.168 0.07 DBMET03750 | DBMET03750 | |
| 0.069 | 0.108 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 DBMET03748 0.08 0.078 DBMET03750 0.081 0.076 DBMET03747 | DBMET03748 | |
| 0.08 | 0.119 | 0.202 | Acetylcholine muscarinic antagonist | 0.202 0.024 DBMET03750 | DBMET03750 | |
| 0.013 | 0.054 | 0.021 | Retinoic acid beta receptor agonist | 0.021 0.012 DBMET03750 | DBMET03750 | |
| 0.015 | 0.058 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.014 DBMET03750 | DBMET03750 | |
| 0.098 | 0.142 | 0.124 | Cholinergic | 0.124 0.102 DBMET03750 | DBMET03750 | |
| 0.044 | 0.089 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 DBMET03750 | DBMET03750 | |
| 0.103 | 0.149 | 0.135 | Farnesoid X receptor antagonist | 0.135 0.073 DBMET03746 0.132 0.08 DBMET03750 | DBMET03746 | |
| 0.031 | 0.079 | 0.051 | DNA gyrase subunit A inhibitor | 0.051 0.016 DBMET03750 | DBMET03750 | |
| 0.073 | 0.125 | 0.156 | DNA polymerase I inhibitor | 0.126 0.064 DBMET03748 0.156 0.046 DBMET03750 | DBMET03750 | |
| 0.013 | 0.067 | 0.022 | Retinoic acid receptor agonist | 0.022 0.018 DBMET03750 | DBMET03750 | |
| 0.035 | 0.09 | 0.076 | Nicotinic receptor alpha4 subunit antagonist | 0.076 0.014 DBMET03750 | DBMET03750 | |
| 0.112 | 0.167 | 0.135 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.135 0.104 DBMET03746 | DBMET03746 | |
| 0.095 | 0.151 | 0.244 | Acetylcholine M1 receptor antagonist | 0.244 0.027 DBMET03750 | DBMET03750 | |
| 0.015 | 0.073 | 0.024 | NMDA 2D receptor antagonist | 0.024 0.023 DBMET03750 | DBMET03750 | |
| 0.121 | 0.183 | 0.143 | Heat shock protein 70 antagonist | 0.135 0.096 DBMET03746 0.143 0.065 DBMET03750 | DBMET03750 | |
| 0.08 | 0.143 | 0.164 | Cyclooxygenase 3 inhibitor | 0.163 0.038 DBMET03748 0.164 0.038 DBMET03750 | DBMET03750 | |
| 0.054 | 0.12 | 0.102 | MDM2 inhibitor | 0.102 0.006 DBMET03750 | DBMET03750 | |
| 0.027 | 0.093 | 0.055 | Neuraminidase (Influenza A) inhibitor | 0.055 0.018 DBMET03750 | DBMET03750 | |
| 0.049 | 0.115 | 0.077 | Somatostatin 1 agonist | 0.077 0.055 DBMET03750 | DBMET03750 | |
| 0.032 | 0.098 | 0.09 | Acetylcholine M3 receptor antagonist | 0.09 0.021 DBMET03750 | DBMET03750 | |
| 0.109 | 0.175 | 0.302 | Hepatoprotectant | 0.302 0.029 DBMET03748 0.134 0.128 DBMET03750 0.258 0.041 DBMET03747 | DBMET03748 | |
| 0.096 | 0.163 | 0.436 | Angiogenesis stimulant | 0.436 0.017 DBMET03748 0.134 0.133 DBMET03749 0.215 0.087 DBMET03750 0.357 0.031 DBMET03747 | DBMET03748 | |
| 0.062 | 0.13 | 0.153 | Expectorant | 0.153 0.034 DBMET03748 0.141 0.039 DBMET03750 | DBMET03748 | |
| 0.136 | 0.205 | 0.342 | Hypoglycemic | 0.342 0.04 DBMET03748 0.192 0.12 DBMET03750 0.231 0.089 DBMET03747 | DBMET03748 | |
| 0.079 | 0.151 | 0.203 | Lipid peroxidase inhibitor | 0.203 0.041 DBMET03748 0.171 0.055 DBMET03747 | DBMET03748 | |
| 0.106 | 0.18 | 0.161 | DNA methylase inhibitor | 0.161 0.108 DBMET03746 0.145 0.122 DBMET03748 | DBMET03746 | |
| 0.015 | 0.089 | 0.027 | Purinergic P2Y14 antagonist | 0.027 0.026 DBMET03750 | DBMET03750 | |
| 0.006 | 0.084 | 0.02 | Calcium-sensing receptor antagonist | 0.02 0.008 DBMET03750 | DBMET03750 | |
| 0.034 | 0.118 | 0.07 | Adrenaline uptake inhibitor | 0.07 0.034 DBMET03750 | DBMET03750 | |
| 0.027 | 0.115 | 0.115 | Dopamine uptake inhibitor | 0.115 0.015 DBMET03750 | DBMET03750 | |
| 0.093 | 0.183 | 0.203 | NOS3 expression enhancer | 0.132 0.094 DBMET03746 0.164 0.06 DBMET03748 0.203 0.04 DBMET03747 | DBMET03747 | |
| 0.059 | 0.153 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 DBMET03748 0.083 0.063 DBMET03750 0.1 0.039 DBMET03747 | DBMET03748 | |
| 0.016 | 0.11 | 0.035 | Nicotinic receptor beta4 subunit antagonist | 0.035 0.028 DBMET03750 | DBMET03750 | |
| 0.052 | 0.146 | 0.092 | Bronchodilator | 0.092 0.073 DBMET03749 | DBMET03749 | |
| 0.042 | 0.137 | 0.059 | Beta 3 adrenoreceptor antagonist | 0.059 0.057 DBMET03750 | DBMET03750 | |
| 0.061 | 0.157 | 0.206 | Cholesterol synthesis inhibitor | 0.206 0.025 DBMET03750 | DBMET03750 | |
| 0.027 | 0.125 | 0.079 | Acetylcholine M5 receptor agonist | 0.079 0.035 DBMET03750 | DBMET03750 | |
| 0.029 | 0.137 | 0.086 | Neuronal nicotinic receptor antagonist | 0.086 0.032 DBMET03750 | DBMET03750 | |
| 0.062 | 0.17 | 0.142 | Mucolytic | 0.142 0.037 DBMET03750 | DBMET03750 | |
| 0.074 | 0.182 | 0.096 | Factor V inhibitor | 0.096 0.079 DBMET03750 | DBMET03750 | |
| 0.04 | 0.149 | 0.109 | Calcium channel L-type blocker | 0.109 0.02 DBMET03750 | DBMET03750 | |
| 0.024 | 0.133 | 0.081 | Neuraminidase inhibitor | 0.081 0.025 DBMET03750 | DBMET03750 | |
| 0.033 | 0.143 | 0.083 | Neuraminidase (influenza) inhibitor | 0.083 0.023 DBMET03750 | DBMET03750 | |
| 0.105 | 0.217 | 0.351 | Free radical scavenger | 0.351 0.039 DBMET03748 0.31 0.049 DBMET03747 | DBMET03748 | |
| 0.047 | 0.164 | 0.106 | Mediator release inhibitor | 0.106 0.062 DBMET03748 0.103 0.066 DBMET03750 0.1 0.07 DBMET03747 | DBMET03748 | |
| 0.022 | 0.14 | 0.056 | Acetylcholine M2 receptor antagonist | 0.056 0.048 DBMET03750 | DBMET03750 | |
| 0.085 | 0.215 | 0.205 | Insulin secretagoues | 0.163 0.061 DBMET03748 0.205 0.033 DBMET03750 | DBMET03750 | |
| 0.093 | 0.223 | 0.193 | Hypolipemic | 0.158 0.129 DBMET03748 0.193 0.1 DBMET03750 | DBMET03750 | |
| 0.066 | 0.197 | 0.168 | Cytidine deaminase inhibitor | 0.168 0.063 DBMET03750 | DBMET03750 | |
| 0.013 | 0.147 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET03750 | DBMET03750 | |
| 0.068 | 0.202 | 0.125 | Cell adhesion inhibitor | 0.125 0.062 DBMET03748 | DBMET03748 | |
| 0.061 | 0.195 | 0.695 | Alpha-N-acetylglucosaminidase inhibitor | 0.695 0.003 DBMET03750 | DBMET03750 | |
| 0.009 | 0.146 | 0.063 | 5-Alpha-reductase inhibitor | 0.063 0.015 DBMET03750 | DBMET03750 | |
| 0.198 | 0.336 | 0.584 | Antiinflammatory | 0.584 0.058 DBMET03748 0.302 0.214 DBMET03750 0.43 0.121 DBMET03747 | DBMET03748 | |
| 0.109 | 0.248 | 0.288 | Cyclic AMP phosphodiesterase inhibitor | 0.288 0.047 DBMET03750 | DBMET03750 | |
| 0.084 | 0.226 | 0.244 | Nitric oxide antagonist | 0.244 0.053 DBMET03748 0.241 0.054 DBMET03747 | DBMET03748 | |
| 0.071 | 0.215 | 0.186 | Protein kinase stimulant | 0.186 0.047 DBMET03750 0.109 0.105 DBMET03747 | DBMET03750 | |
| 0.151 | 0.295 | 0.364 | Interleukin 2 agonist | 0.227 0.147 DBMET03746 0.342 0.049 DBMET03748 0.223 0.152 DBMET03749 0.246 0.124 DBMET03750 0.364 0.04 DBMET03747 | DBMET03747 | |
| 0.01 | 0.155 | 0.089 | Acetylcholine M1 receptor agonist | 0.089 0.014 DBMET03750 | DBMET03750 | |
| 0.014 | 0.161 | 0.11 | Acetylcholine muscarinic agonist | 0.11 0.015 DBMET03750 | DBMET03750 | |
| 0.008 | 0.156 | 0.024 | Motilin receptor agonist | 0.024 0.014 DBMET03747 | DBMET03747 | |
| 0.123 | 0.274 | 0.531 | Cholesterol antagonist | 0.276 0.107 DBMET03748 0.531 0.028 DBMET03750 | DBMET03750 | |
| 0.026 | 0.177 | 0.056 | Heparanase inhibitor | 0.056 0.029 DBMET03748 | DBMET03748 | |
| 0.066 | 0.217 | 0.113 | Interleukin 4 antagonist | 0.113 0.096 DBMET03746 | DBMET03746 | |
| 0.183 | 0.338 | 0.365 | 5 Hydroxytryptamine release inhibitor | 0.365 0.103 DBMET03750 | DBMET03750 | |
| 0.062 | 0.22 | 0.354 | Psychostimulant | 0.354 0.031 DBMET03750 | DBMET03750 | |
| 0.018 | 0.177 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.017 DBMET03748 0.044 0.017 DBMET03747 | DBMET03748 | |
| 0.116 | 0.274 | 0.449 | Transcription factor NF kappa B inhibitor | 0.449 0.053 DBMET03748 0.228 0.144 DBMET03750 0.3 0.094 DBMET03747 | DBMET03748 | |
| 0.081 | 0.243 | 0.183 | Hemostatic | 0.182 0.041 DBMET03748 0.183 0.04 DBMET03750 | DBMET03750 | |
| 0.035 | 0.198 | 0.127 | Topoisomerase I inhibitor | 0.127 0.052 DBMET03748 0.105 0.066 DBMET03747 | DBMET03748 | |
| 0.02 | 0.187 | 0.179 | Selectin antagonist | 0.179 0.014 DBMET03748 0.144 0.019 DBMET03747 | DBMET03748 | |
| 0.034 | 0.206 | 0.091 | Adrenaline agonist | 0.091 0.044 DBMET03750 | DBMET03750 | |
| 0.013 | 0.185 | 0.042 | Factor XIa inhibitor | 0.042 0.027 DBMET03750 | DBMET03750 | |
| 0.131 | 0.305 | 0.367 | Antiobesity | 0.367 0.079 DBMET03750 | DBMET03750 | |
| 0.048 | 0.224 | 0.105 | Protein kinase C gamma inhibitor | 0.105 0.069 DBMET03746 | DBMET03746 | |
| 0.074 | 0.252 | 0.131 | DNA methyltransferase I inhibitor | 0.131 0.129 DBMET03750 | DBMET03750 | |
| 0.023 | 0.204 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.046 DBMET03746 | DBMET03746 | |
| 0.037 | 0.222 | 0.11 | Glycine receptor agonist | 0.11 0.016 DBMET03750 | DBMET03750 | |
| 0.055 | 0.241 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.074 DBMET03750 | DBMET03750 | |
| 0.007 | 0.193 | 0.02 | 5-Alpha-reductase 2 inhibitor | 0.02 0.013 DBMET03750 | DBMET03750 | |
| 0.119 | 0.307 | 0.283 | Vasodilator, coronary | 0.265 0.119 DBMET03748 0.283 0.102 DBMET03750 0.194 0.187 DBMET03747 | DBMET03750 | |
| 0.017 | 0.204 | 0.089 | Antineoplastic antibiotic | 0.072 0.063 DBMET03748 0.089 0.052 DBMET03747 | DBMET03747 | |
| 0.069 | 0.256 | 0.392 | Anesthetic general | 0.392 0.017 DBMET03750 | DBMET03750 | |
| 0.016 | 0.204 | 0.029 | DNA topoisomerase IV inhibitor | 0.029 0.024 DBMET03750 | DBMET03750 | |
| 0.118 | 0.308 | 0.3 | Immunomodulator | 0.3 0.082 DBMET03748 0.224 0.138 DBMET03750 0.199 0.165 DBMET03747 | DBMET03748 | |
| 0.049 | 0.241 | 0.163 | Thrombolytic | 0.162 0.073 DBMET03748 0.14 0.09 DBMET03750 0.163 0.073 DBMET03747 | DBMET03747 | |
| 0.13 | 0.325 | 0.332 | Apoptosis antagonist | 0.324 0.07 DBMET03748 0.332 0.065 DBMET03747 | DBMET03747 | |
| 0.038 | 0.234 | 0.086 | Prolactin inhibitor | 0.086 0.071 DBMET03750 | DBMET03750 | |
| 0.077 | 0.275 | 0.135 | Melanin inhibitor | 0.135 0.106 DBMET03747 | DBMET03747 | |
| 0.035 | 0.238 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.046 DBMET03750 | DBMET03750 | |
| 0.051 | 0.255 | 0.121 | Microtubule formation inhibitor | 0.121 0.06 DBMET03750 | DBMET03750 | |
| 0.021 | 0.225 | 0.129 | Phenylalanine 4-hydroxylase inhibitor | 0.129 0.016 DBMET03750 | DBMET03750 | |
| 0.08 | 0.286 | 0.143 | Interferon gamma antagonist | 0.143 0.088 DBMET03750 0.125 0.123 DBMET03747 | DBMET03750 | |
| 0.047 | 0.254 | 0.112 | Bone formation stimulant | 0.112 0.094 DBMET03750 | DBMET03750 | |
| 0.016 | 0.224 | 0.059 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET03748 0.059 0.031 DBMET03747 | DBMET03747 | |
| 0.016 | 0.224 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.044 DBMET03750 | DBMET03750 | |
| 0.056 | 0.266 | 0.154 | Anticoagulant | 0.143 0.087 DBMET03748 0.154 0.077 DBMET03750 0.133 0.097 DBMET03747 | DBMET03750 | |
| 0.023 | 0.236 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.04 DBMET03750 | DBMET03750 | |
| 0.104 | 0.317 | 0.406 | DNA synthesis inhibitor | 0.185 0.146 DBMET03748 0.406 0.021 DBMET03750 0.175 0.16 DBMET03747 | DBMET03750 | |
| 0.02 | 0.234 | 0.128 | Histidine decarboxylase inhibitor | 0.128 0.023 DBMET03750 | DBMET03750 | |
| 0.014 | 0.236 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 DBMET03750 | DBMET03750 | |
| 0.059 | 0.281 | 0.265 | Cell wall synthesis inhibitor | 0.145 0.07 DBMET03748 0.265 0.013 DBMET03750 | DBMET03750 | |
| 0.019 | 0.243 | 0.084 | Androgen agonist | 0.084 0.022 DBMET03750 | DBMET03750 | |
| 0.007 | 0.24 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.028 0.005 DBMET03750 | DBMET03750 | |
| 0.034 | 0.267 | 0.081 | Keratolytic | 0.081 0.047 DBMET03750 | DBMET03750 | |
| 0.097 | 0.335 | 0.333 | 5 Hydroxytryptamine release stimulant | 0.333 0.061 DBMET03750 | DBMET03750 | |
| 0.052 | 0.292 | 0.118 | Nav1.2 sodium channel blocker | 0.118 0.086 DBMET03750 | DBMET03750 | |
| 0.118 | 0.36 | 0.542 | Antibacterial | 0.453 0.056 DBMET03748 0.409 0.072 DBMET03750 0.542 0.03 DBMET03747 | DBMET03747 | |
| 0.012 | 0.257 | 0.051 | Adenosine deaminase inhibitor | 0.051 0.029 DBMET03750 | DBMET03750 | |
| 0.049 | 0.301 | 0.093 | Glutamate (mGluR7) agonist | 0.093 0.075 DBMET03750 | DBMET03750 | |
| 0.093 | 0.347 | 0.274 | Gastrin inhibitor | 0.274 0.054 DBMET03750 | DBMET03750 | |
| 0.023 | 0.279 | 0.083 | Nicotinic alpha3beta2 receptor antagonist | 0.083 0.012 DBMET03750 | DBMET03750 | |
| 0.022 | 0.278 | 0.08 | Acetylcholine nicotinic agonist | 0.08 0.056 DBMET03750 | DBMET03750 | |
| 0.019 | 0.278 | 0.218 | NMDA receptor antagonist | 0.218 0.012 DBMET03750 | DBMET03750 | |
| 0.06 | 0.326 | 0.436 | Aldehyde oxidase inhibitor | 0.436 0.042 DBMET03750 | DBMET03750 | |
| 0.011 | 0.281 | 0.042 | Sphingosine 1-phosphate receptor agonist | 0.042 0.034 DBMET03750 | DBMET03750 | |
| 0.107 | 0.381 | 0.256 | Peptidyltransferase inhibitor | 0.256 0.046 DBMET03748 0.174 0.139 DBMET03750 0.229 0.067 DBMET03747 | DBMET03748 | |
| 0.057 | 0.331 | 0.304 | Interleukin agonist | 0.304 0.046 DBMET03750 | DBMET03750 | |
| 0.063 | 0.338 | 0.167 | Antipruritic | 0.167 0.076 DBMET03750 | DBMET03750 | |
| 0.11 | 0.399 | 0.257 | Caspase 3 stimulant | 0.218 0.145 DBMET03748 0.257 0.106 DBMET03747 | DBMET03747 | |
| 0.006 | 0.297 | 0.134 | NMDA 2 receptor antagonist | 0.134 0.02 DBMET03750 | DBMET03750 | |
| 0.034 | 0.336 | 0.096 | Bile acid receptor antagonist | 0.096 0.058 DBMET03750 | DBMET03750 | |
| 0.006 | 0.309 | 0.079 | Purinergic P2Y antagonist | 0.079 0.013 DBMET03750 | DBMET03750 | |
| 0.011 | 0.315 | 0.142 | Alcohol oxidase inhibitor | 0.142 0.011 DBMET03750 | DBMET03750 | |
| 0.108 | 0.415 | 0.268 | Tyrosine 3 hydroxylase inhibitor | 0.268 0.053 DBMET03750 | DBMET03750 | |
| 0.013 | 0.323 | 0.103 | Nicotinic alpha4beta2 receptor antagonist | 0.103 0.029 DBMET03750 | DBMET03750 | |
| 0.074 | 0.385 | 0.444 | Superoxide dismutase inhibitor | 0.444 0.02 DBMET03750 | DBMET03750 | |
| 0.119 | 0.431 | 0.423 | 5 Hydroxytryptamine uptake stimulant | 0.423 0.01 DBMET03750 | DBMET03750 | |
| 0.008 | 0.322 | 0.124 | NMDA 2C receptor antagonist | 0.124 0.01 DBMET03750 | DBMET03750 | |
| 0.022 | 0.337 | 0.096 | Potassium channel (Ca-activated) activator | 0.096 0.058 DBMET03750 | DBMET03750 | |
| 0.011 | 0.328 | 0.048 | Dihydroorotase inhibitor | 0.048 0.026 DBMET03750 | DBMET03750 | |
| 0.029 | 0.356 | 0.09 | Glutamate (mGluR6) antagonist | 0.09 0.016 DBMET03750 | DBMET03750 | |
| 0.012 | 0.342 | 0.075 | Catalase inhibitor | 0.075 0.051 DBMET03750 | DBMET03750 | |
| 0.022 | 0.354 | 0.119 | Glutamate receptor antagonist | 0.119 0.075 DBMET03750 | DBMET03750 | |
| 0.013 | 0.347 | 0.039 | GABA B receptor antagonist | 0.039 0.038 DBMET03750 | DBMET03750 | |
| 0.026 | 0.367 | 0.192 | UDP-glucose 4-epimerase inhibitor | 0.192 0.019 DBMET03750 | DBMET03750 | |
| 0.062 | 0.403 | 0.393 | Alpha-glucosidase inhibitor | 0.376 0.125 DBMET03748 0.393 0.118 DBMET03747 | DBMET03747 | |
| 0.042 | 0.383 | 0.314 | Immunostimulant | 0.314 0.075 DBMET03748 0.249 0.096 DBMET03750 0.16 0.146 DBMET03747 | DBMET03748 | |
| 0.008 | 0.35 | 0.037 | Glutamate (mGluR3) antagonist | 0.037 0.025 DBMET03750 | DBMET03750 | |
| 0.019 | 0.361 | 0.08 | Antihistaminic | 0.08 0.078 DBMET03750 | DBMET03750 | |
| 0.039 | 0.382 | 0.092 | Phosphodiesterase 6D inhibitor | 0.092 0.07 DBMET03750 | DBMET03750 | |
| 0.031 | 0.376 | 0.14 | Triose-phosphate isomerase inhibitor | 0.14 0.023 DBMET03750 | DBMET03750 | |
| 0.01 | 0.357 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 DBMET03750 | DBMET03750 | |
| 0.077 | 0.427 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.16 0.127 DBMET03750 | DBMET03750 | |
| 0.031 | 0.383 | 0.113 | Nav1.3 sodium channel blocker | 0.113 0.081 DBMET03750 | DBMET03750 | |
| 0.067 | 0.421 | 0.19 | Sphingosine 1-phosphate receptor 5 antagonist | 0.19 0.016 DBMET03750 | DBMET03750 | |
| 0.004 | 0.361 | 0.056 | NMDA receptor subunit 3A antagonist | 0.056 0.018 DBMET03750 | DBMET03750 | |
| 0.011 | 0.368 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 DBMET03750 | DBMET03750 | |
| 0.031 | 0.394 | 0.107 | Amylase inhibitor | 0.107 0.091 DBMET03750 | DBMET03750 | |
| 0.014 | 0.382 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.027 DBMET03750 | DBMET03750 | |
| 0.033 | 0.406 | 0.254 | Adenylate cyclase inhibitor | 0.254 0.019 DBMET03750 | DBMET03750 | |
| 0.095 | 0.469 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.145 DBMET03750 | DBMET03750 | |
| 0.041 | 0.424 | 0.12 | Adenylate kinase inhibitor | 0.12 0.043 DBMET03750 | DBMET03750 | |
| 0.008 | 0.392 | 0.049 | Carbonic anhydrase XIV inhibitor | 0.049 0.034 DBMET03750 | DBMET03750 | |
| 0.011 | 0.411 | 0.061 | Aconitate hydratase inhibitor | 0.061 0.025 DBMET03750 | DBMET03750 | |
| 0.044 | 0.45 | 0.19 | Succinate dehydrogenase inhibitor | 0.19 0.058 DBMET03750 | DBMET03750 | |
| 0.01 | 0.418 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 DBMET03750 | DBMET03750 | |
| 0.049 | 0.458 | 0.122 | DNA repair enzyme inhibitor | 0.122 0.069 DBMET03750 | DBMET03750 | |
| 0.019 | 0.437 | 0.096 | Ornithine decarboxylase inhibitor | 0.096 0.049 DBMET03750 | DBMET03750 | |
| 0.01 | 0.429 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 DBMET03750 | DBMET03750 | |
| 0.026 | 0.455 | 0.113 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 DBMET03750 | DBMET03750 | |
| 0.008 | 0.449 | 0.082 | Biliverdin reductase inhibitor | 0.082 0.025 DBMET03750 | DBMET03750 | |
| 0.033 | 0.48 | 0.141 | Sphingosine 1-phosphate receptor 4 antagonist | 0.141 0.042 DBMET03750 | DBMET03750 | |
| 0.027 | 0.484 | 0.11 | NADH dehydrogenase inhibitor | 0.11 0.035 DBMET03750 | DBMET03750 | |
| 0.007 | 0.468 | 0.069 | Argininosuccinate synthase inhibitor | 0.069 0.031 DBMET03750 | DBMET03750 | |
| 0.017 | 0.484 | 0.122 | Creatine kinase inhibitor | 0.122 0.039 DBMET03750 | DBMET03750 | |
| 0.043 | 0.511 | 0.196 | Phospholipase C inhibitor | 0.196 0.046 DBMET03750 | DBMET03750 | |
| 0.004 | 0.48 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DBMET03750 | DBMET03750 | |
| 0.006 | 0.488 | 0.075 | Mannosidase inhibitor | 0.075 0.01 DBMET03750 | DBMET03750 | |
| 0.025 | 0.506 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.047 DBMET03750 | DBMET03750 | |
| 0.018 | 0.518 | 0.095 | Glutamate dehydrogenase inhibitor | 0.095 0.034 DBMET03750 | DBMET03750 | |
| 0.014 | 0.515 | 0.06 | Glucosylceramidase inhibitor | 0.06 0.03 DBMET03750 | DBMET03750 | |
| 0.011 | 0.511 | 0.077 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET03750 | DBMET03750 | |
| 0.008 | 0.517 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.012 DBMET03750 | DBMET03750 | |
| 0.018 | 0.535 | 0.13 | GABA C receptor rho-1 antagonist | 0.13 0.032 DBMET03750 | DBMET03750 | |
| 0.019 | 0.541 | 0.206 | Anticonvulsant | 0.206 0.078 DBMET03750 | DBMET03750 | |
| 0.008 | 0.532 | 0.07 | Glutamate decarboxylase inhibitor | 0.07 0.054 DBMET03750 | DBMET03750 | |
| 0.005 | 0.531 | 0.078 | Acyl-CoA dehydrogenase inhibitor | 0.078 0.023 DBMET03750 | DBMET03750 | |
| 0.001 | 0.543 | 0.038 | Arginase inhibitor | 0.038 0.024 DBMET03750 | DBMET03750 | |
| 0.003 | 0.553 | 0.046 | Ornithine carbamoyltransferase inhibitor | 0.046 0.043 DBMET03750 | DBMET03750 | |
| 0.029 | 0.586 | 0.128 | Adenylate cyclase stimulant | 0.128 0.105 DBMET03750 | DBMET03750 | |
| 0.011 | 0.569 | 0.067 | Phospholipase D inhibitor | 0.067 0.06 DBMET03750 | DBMET03750 | |
| 0.018 | 0.576 | 0.127 | Cathepsin H inhibitor | 0.127 0.067 DBMET03750 | DBMET03750 | |
| 0.016 | 0.581 | 0.087 | Anabolic | 0.087 0.085 DBMET03750 | DBMET03750 | |
| 0.014 | 0.581 | 0.188 | GABA C receptor agonist | 0.188 0.023 DBMET03750 | DBMET03750 | |
| 0.018 | 0.587 | 0.127 | Sphingosine 1-phosphate receptor 2 antagonist | 0.127 0.08 DBMET03750 | DBMET03750 | |
| 0.047 | 0.62 | 0.2 | Insulysin inhibitor | 0.2 0.156 DBMET03750 | DBMET03750 | |
| 0.015 | 0.602 | 0.09 | Aminopeptidase B inhibitor | 0.09 0.073 DBMET03750 | DBMET03750 | |
| 0.004 | 0.61 | 0.06 | Phosphofructokinase-1 inhibitor | 0.06 0.056 DBMET03750 | DBMET03750 | |
| 0.016 | 0.647 | 0.085 | Electrolyte absorption antagonist | 0.085 0.084 DBMET03750 | DBMET03750 | |
| 0.01 | 0.66 | 0.117 | Ferrochelatase inhibitor | 0.117 0.056 DBMET03750 | DBMET03750 | |
| 0.009 | 0.695 | 0.127 | GABA C receptor antagonist | 0.127 0.046 DBMET03750 | DBMET03750 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |